Document ID: FEMA-2020-0016-0040
Agency: fema
Document Type: Notice
Title: Voluntary Agreement under the Defense Production Act: Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic
Posted Date: 2020-08-17T04:00Z

[Federal Register Volume 85, Number 159 (Monday, August 17, 2020)]
[Notices]
[Pages 50035-50040]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18005]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2020-0016]

Voluntary Agreement Under Section 708 of the Defense Production 
Act; Manufacture and Distribution of Critical Healthcare Resources 
Necessary To Respond to a Pandemic

AGENCY: Federal Emergency Management Agency, Homeland Security (DHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) announces the 
formation of a voluntary agreement under Section 708 of the Defense 
Production Act for the Manufacture and Distribution of Critical 
Healthcare Resources Necessary to Respond to a Pandemic. This Notice 
contains the text of the Voluntary Agreement.

FOR FURTHER INFORMATION CONTACT: Harold Lucie, Joint DPA Office, 
Federal Emergency Management Agency, 500 C Street SW, Washington, DC 
20472-3184, telephone (202) 212-2900, and email FEMA-DPA@fema.dhs.gov.

SUPPLEMENTARY INFORMATION: 

Authority

    Section 708 of the Defense Production Act (DPA), 50 U.S.C. 4558, 
allows the President to provide for the formation of voluntary 
agreements by the private sector to help provide for the national 
defense. This authority was delegated to the Secretary of Homeland 
Security generally in section 401 of Executive Order 13603,\1\ 
``National Defense Resources Preparedness,'' and specifically for 
response to COVID-19 in section 3 of Executive Order 13911,\2\ 
``Delegating Additional Authority Under the Defense Production Act With 
Respect to Health and Medical Resources To Respond to the Spread of 
COVID-19.'' The Secretary of Homeland Security has delegated these 
authorities to the FEMA Administrator in Department of Homeland 
Security (DHS) Delegation 09052 Rev. 00, ``Delegation of Defense 
Production Act Authority to the Administrator of the Federal Emergency 
Management Agency,'' (Jan. 3, 2017), and DHS Delegation 09052 Rev. 
00.1, ``Delegation of Defense Production Act Authority to the 
Administrator of the Federal Emergency Management Agency'' (Apr. 1, 
2020), respectively.
---------------------------------------------------------------------------

    \1\ 77 FR 16651 (Mar. 22, 2012).
    \2\ 85 FR 18403 (Apr. 1, 2020).
---------------------------------------------------------------------------

Background

    FEMA sought and received approval from the Attorney General, after 
consultation with the Federal Trade Commission (FTC), to begin 
consultation with the private sector, as required by Section 708(c)(2). 
Pursuant to that approval, on May 12, 2020, FEMA posted an announcement 
of a public meeting and request for comments to develop a Voluntary 
Agreement in the Federal Register (85 FR 28031). FEMA held a public 
meeting on May 21, 2020, and accepted public comments until June 5, 
2020.\3\ FEMA received 34 public comments and considered these comments 
when preparing the Voluntary Agreement.\4\
---------------------------------------------------------------------------

    \3\ The original comment period was extended to allow 
commentators additional time to respond. FEMA posted notices of 
extension to www.regulations.gov under the Docket ID for this 
notice, FEMA-2020-0016.
    \4\ Available on www.regulations.gov under Docket ID for this 
notice.
---------------------------------------------------------------------------

    The Attorney General, in consultation with the Chairman of the 
Federal Trade Commission, made the required finding that the purpose of 
the voluntary agreement may not reasonably be achieved through an 
agreement having less anticompetitive effect or without any voluntary 
agreement. Pursuant to Sec. 708(f)(1)(B) of the Defense Production Act, 
the Department of Justice is separately publishing this finding in this 
issue of the Federal Register as a notice. The FEMA Administrator, as 
the Sponsor of the agreement, has certified in writing that the 
agreement is necessary to help provide for the national defense.

Text of the Voluntary Agreement, Manufacture and Distribution of 
Critical Healthcare Resources Necessary To Respond to a Pandemic

Table of Contents

Preface
I. Purpose
II. Authorities
III. General Provisions
    A. Definitions
    B. Committee Participation
    C. Effective Date and Duration of Participation
    D. Withdrawal
    E. Plan of Action Activation and Deactivation
    F. Rules and Regulations
    G. Modification and Amendment
    H. Expenses
    I. Record Keeping
IV. Antitrust Defense
V. Terms and Conditions
    A. Plan of Action Execution
    B. Information Management and Responsibilities
    C. Oversight
VI. Establishment of the Committee
VII. Application and Agreement
VIII. Assignment

Voluntary Agreement, Manufacture and Distribution of Critical 
Healthcare Resources Necessary To Respond to a Pandemic

Preface

    Pursuant to section 708 of the Defense Production Act of 1950 
(DPA), as amended (50 U.S.C. 4558), the Federal Emergency Management 
Agency (FEMA) Administrator (Administrator), after consultation with 
the Secretary of the Department of Health and Human Services (HHS), the 
Attorney General of the United States (Attorney General), and the 
Chairman of the Federal Trade Commission (FTC), has developed this 
Voluntary Agreement (Agreement). This Agreement is intended to maximize 
the effectiveness of the manufacture and distribution of Critical 
Healthcare Resources nationwide to respond to a pandemic by 
establishing unity of effort between the Participants and the Federal 
Government for integrated coordination, planning, information sharing 
with FEMA, and allocation and distribution of Critical Healthcare 
Resources. The activities contemplated by this Agreement are limited to 
those necessary to respond to a Pandemic, at the sole determination of 
FEMA. This Agreement affords Participants defenses

[[Page 50036]]

to civil and criminal actions brought for violations of antitrust laws 
when carrying out this Agreement and an appropriate Plan of Action. 
This Agreement is intended to foster a close working relationship among 
FEMA, HHS, and the Participants to address national defense needs 
through cooperative action under the direction and supervision of FEMA. 
This Agreement, when implemented through a Plan of Action, affords 
Participants a safe harbor to exchange information, collaborate and 
adjust commercial operations as to particular products and services, 
when FEMA determines it necessary for the national defense, and only to 
the extent necessary for the national defense.

I. Purpose

    A pandemic may present conditions that pose a direct threat to the 
national defense of the United States or its preparedness programs such 
that, pursuant to DPA section 708(c)(1), an agreement to collectively 
coordinate, plan and collaborate for the manufacture and distribution 
of personal protective equipment (PPE), Pharmaceuticals and other 
Critical Healthcare Resources is necessary for the national defense. 
This Agreement will maximize the effectiveness of the manufacture and 
distribution of Critical Healthcare Resources nationwide to respond to 
a pandemic by establishing unity of effort between the Participants and 
the Federal Government for integrated coordination, planning, 
information sharing with FEMA, allocation and distribution of Critical 
Healthcare Resources. The activities included in this Agreement are 
limited to those necessary to respond to a Pandemic, at the sole 
determination, direction, and supervision of FEMA and implemented 
through Plans of Action.

II. Authorities

    Section 708, Defense Production Act (50 U.S.C. 4558); sections 
402(2) & 501(b), Robert T. Stafford Disaster Relief and Emergency 
Assistance Act (42 U.S.C. 5121-5207); sections 503(b)(2)(B) & 
504(a)(10) & (16) of the Homeland Security Act of 2002 (6 U.S.C. 
313(b)(2)(B), 314(a)(10) & (16)); sections 201, 301, National 
Emergencies Act (50 U.S.C. 1601 et seq.); section 319, Public Health 
Service Act (42 U.S.C. 247d); Executive Order (E.O.) 13911, 85 FR 18403 
(Mar. 27, 2020); Prioritization and Allocation of Certain Scarce or 
Threatened Health and Medical Resources for Domestic Use, 85 FR 20195 
(Apr. 10, 2020). Pursuant to DPA section 708(f)(1)(A), the 
Administrator certifies that this Agreement is necessary for the 
national defense.

III. General Provisions

A. Definitions

Administrator
    The FEMA Administrator who, as a Presidentially appointed and 
Senate confirmed official, is the Sponsor of this Agreement. Pursuant 
to a delegation or redelegation of the functions given to the President 
by DPA section 708, the Administrator proposes and provides for the 
development and carrying out of this Agreement. The Administrator is 
responsible for carrying out all duties and responsibilities required 
by 50 U.S.C. 4558 and 44 CFR part 332 and for appointing one or more 
Chairpersons to manage and administer the Committee and any Sub-
Committee formed to carry out this Agreement.
Agreement
    The Voluntary Agreement. Participants who have been invited to join 
and agreed to the terms of this Agreement as described in Section VII 
below may join the ``Committee for the Distribution of Healthcare 
Resources Necessary to Respond to a Pandemic.''
Attendees
    Subject matter experts, invited by the Chairperson to attend 
meetings authorized under this Agreement, to provide technical advice 
or to represent other Government agencies or interested parties. 
Attendees are not Members of the Committee.
Chairperson
    FEMA senior executive, appointed by the Administrator, to chair the 
``Committee for the Distribution of Healthcare Resources Necessary to 
Respond to a Pandemic.'' The Chairperson shall be responsible for the 
overall management and administration of the Committee, this Agreement, 
and Plans of Action developed under this Agreement while remaining 
under the supervision of the Administrator; may create one or more Sub-
Committees, as approved by the Administrator; shall initiate, or 
approve in advance, each meeting held to discuss problems, determine 
policies, recommend actions, and make decisions necessary to carry out 
this Agreement; and otherwise shall carry out all duties and 
responsibilities assigned to him. The Administrator may appoint one or 
more co-Chairpersons to chair the Committee and Sub-Committees, as 
appropriate.
Committee
    Committee for the Distribution of Healthcare Resources Necessary to 
Respond to a Pandemic established under this Agreement. Provides 
Committee Members a forum to maximize the effectiveness of the 
manufacture and distribution of Critical Healthcare Resources 
nationwide to respond to a Pandemic through integrated coordination, 
planning, and identification and development of Plans of Action needed 
to respond to a pandemic, including making recommendations on the 
creation of a Plan of Action.
Critical Healthcare Resources
    All categories of health and medical resources for which production 
and distribution capacity is necessary to respond to a pandemic, 
including, but not limited to, PPE, Pharmaceuticals, respiratory 
devices, vaccines, raw materials, supplies, and medical devices.
Documents
    Any information, on paper or in electronic format, including 
written, recorded, and graphic materials of every kind, in the 
possession, custody, or control of the Participant.
Members
    Collectively the Chairperson, Representatives, and Participants of 
the Committee. Jointly responsible for developing all decisions 
necessary to carry out this Agreement and to develop and execute Plans 
of Action under this Agreement.
Pandemic
    A Pandemic is defined as an epidemic that has spread to human 
populations across a large geographic area that is subject to one or 
more declarations under the National Emergencies Act, the Public Health 
Service Act, or the Robert T. Stafford Disaster Relief and Emergency 
Assistance Act, or if the Administrator determines that one or more 
declarations is likely to occur and the epidemic poses a direct threat 
to the national defense or its preparedness programs. For example, 
Coronavirus Disease 2019 (COVID-19).
Participant
    An individual, partnership, corporation, association, or private 
organization, other than a Federal agency, that has substantive 
capabilities, resources or expertise to carry out the purpose of this 
Agreement, that has been specifically invited to participate in this 
Agreement by the Chairperson, and that has applied and agreed to the

[[Page 50037]]

terms of this Agreement in Section VII below. ``Participant'' includes 
a corporate or non-corporate entity entering into this Agreement and 
all subsidiaries and affiliates of that entity in which that entity has 
50 percent or more control either by stock ownership, board majority, 
or otherwise. The Administrator may invite Participants to join this 
Agreement at any time during its effective period.
Personal Protective Equipment
    Objects that provide measures of safety protection for healthcare 
workers, first responders, critical infrastructure personnel and/or the 
general public for the response to the Pandemic. These PPE items may 
include, but are not limited to, face coverings, filtering facepiece 
respirators, face shields, isolation and surgical gowns, examination 
and surgical gloves, suits, and foot coverings.
Pharmaceuticals
    All drugs defined under the Food, Drug, and Cosmetic Act, 21 U.S.C. 
321(g), including biological products defined under the Public Health 
Service Act, 42 U.S.C. 262(i).
Plan of Action
    A documented method, pursuant to 50 U.S.C. 4558(b)(2), proposed by 
FEMA and adopted by invited Participants, to implement this Agreement, 
through a Sub-Committee focused on a particular Critical Healthcare 
Resource, or pandemic response workstream or functional area necessary 
for the national defense.
Plan of Action Agreement
    A separate commitment made by Participants upon invitation and 
agreement to participate in a Plan of Action. Completing the Plan of 
Action Agreement confers responsibilities on the Participant consistent 
with those articulated in the Plan of Action and affords Participants 
antitrust protections for actions taken consistent with that Plan of 
Action as described in Section IV below.
Point of Care
    All categories of medical service providers necessary to respond to 
a pandemic, as determined by the Chairperson after consultation with 
the Members of the Committee. This may include, but is not limited to, 
Acute Care, First Responders, Nursing Homes, Private Hospitals, Public 
Hospitals, Veterans Administration Hospitals, Physician Offices, Dental 
Offices, Ambulatory Clinics, Pharmacies, Community Health Clinics, 
Laboratories, and other acute and non-acute care facilities responsible 
for healthcare.
Representatives
    The representatives the Administrator identifies and invites to the 
Committee from FEMA, HHS, and other Federal agencies with equities in 
this Agreement, and empowered to speak on behalf of their agencies' 
interests. The Attorney General and the Chairman of the FTC, or their 
delegates, may also attend any meeting as a Representative.
Sub-Committee
    A body formed by the Administrator from select Participants to 
implement a Plan of Action.

B. Committee Participation

    The Committee established under this Agreement will consist of the 
(1) Chairperson, (2) Representatives from FEMA, HHS, DOJ, and other 
Federal agencies with equities in this Agreement, and (3) Participants 
that have substantive capabilities, resources or expertise to carry out 
the purpose of this Agreement. Other Attendees--invited by the 
Chairperson as subject matter experts to provide technical advice or to 
represent the interests of other Government agencies or interested 
parties--may also participate in Committee meetings. Collectively, the 
Chairperson, Representatives and Participants will serve as the Members 
of the Committee. Public notice will be provided as each Participant 
joins or withdraws from this Agreement. The list of Participants will 
be published annually in the Federal Register.

C. Effective Date and Duration of Participation

    This Agreement is effective immediately upon the signature of the 
Participant or their authorized designees. This Agreement shall remain 
in effect until terminated in accordance with 44 CFR 332.4, or in any 
case, it shall be effective no more than five (5) years from the date 
the requirements of DPA section 708(f)(1) are satisfied as to the 
initial Voluntary Agreement regarding the manufacture and distribution 
of critical healthcare resources necessary to respond to a Pandemic, 
unless otherwise terminated pursuant to DPA section 708(h)(9) and 44 
CFR 332.4 or extended as set forth in DPA section 708(f)(2). No action 
may take place under this Agreement until it is activated, as described 
in Section III(E.), below.

D. Withdrawal

    Participants may withdraw from this Agreement at any point, subject 
to the fulfillment of obligations incurred under this Agreement prior 
to the date this agreement is terminated with regard to such 
Participant, by giving written notice to the Administrator at least 
fifteen (15) calendar days prior to the effective date of that 
Participant's withdrawal. Following receipt of such notice, the 
Administrator will inform the other Participants of the date of the 
withdrawal.
    Upon the effective date of the withdrawal, the Participant must 
cease all activities under this Agreement.

E. Plan of Action Activation and Deactivation

    Upon occurrence of a Pandemic, the Administrator may authorize a 
Plan of Action and Sub-Committee for one or more specific Pandemic 
response workstreams, functional areas, or Critical Healthcare Resource 
national defense needs, e.g., a pharmaceuticals plan of action, or a 
PPE distribution plan of action, or a vaccine plan of action. The 
Administrator will invite a select group of Participants who are 
representative of the segment of the industry for which the Plan of 
Action is intended to participate on the Sub-Committee. The Plan of 
Action will be activated for each invited Participant when the 
Participant executes a Plan of Action Agreement. Actions taken by 
Participants to develop a Plan of Action and actions taken after 
executing a Plan of Action Agreement to collectively coordinate, plan 
and collaborate, pursuant to that Plan of Action and as directed and 
supervised by FEMA, will constitute action taken to develop and carry 
out this Agreement pursuant to 50 U.S.C. 4558(j).
    Sub-Committees will meet only for the purposes specified in this 
Agreement and as provided for in writing by the Chairperson. They will 
report directly to the Committee regarding all actions taken by them, 
and any Plan of Action adopted by a Sub-Committee must be approved 
first by the Chairperson. A Plan of Action may not become effective 
unless and until the Attorney General (after consultation with the 
Chairman of the Federal Trade Commission) finds, in writing, that such 
purpose(s) of the Plan of Action may not reasonably be achieved through 
a Plan of Action having less anticompetitive effects or without any 
Plan of Action and publishes such finding in the Federal Register. The 
Chairperson may appoint a Sub-Committee Chairperson to preside over 
each Sub-Committee as

[[Page 50038]]

a delegate of the Chairperson; however, the Chairperson retains 
responsibility for all Sub-Committees and for administerial and record 
keeping requirements of any meetings held by such Sub-Committees, 
including providing public notice as required of any meetings.
    When recommended by the Sub-Committee Chairperson, the 
Administrator will provide notice of a Plan of Action Deactivation. Any 
actions taken by Participants after the Deactivation date are outside 
the scope of Plan of Action Agreement and the Section IV antitrust 
defense is not available.

F. Rules and Regulations

    Participants acknowledge and agree to comply with all provisions of 
DPA section 708, as amended, and regulations related thereto which are 
promulgated by FEMA, the Department of Homeland Security, HHS, the 
Attorney General, and the FTC. FEMA has promulgated standards and 
procedures pertaining to voluntary agreements in 44 CFR part 332. The 
Administrator shall inform Participants of new rules and regulations as 
they are issued.

G. Modification and Amendment

    The Administrator, after consultation with the Attorney General and 
the Chairman of the FTC, may terminate or modify, in writing, this 
Agreement or a Plan of Action at any time, and may remove Participants 
from this Agreement or a Plan of Action at any time. Participants may 
propose modifications or amendments to this Agreement at any time. The 
Administrator shall inform Participants of modifications or amendments 
to this Agreement as they are issued. If a Participant indicates an 
intent to withdraw from the Agreement due to a modification or 
amendment of the Agreement, the Participant will not be required to 
perform actions directed by that modification or amendment.
    The Attorney General, after consultation with the Chairman of the 
FTC and the Administrator, may terminate or modify, in writing, this 
Agreement or a Plan of Action at any time, and may remove Participants 
from this Agreement or a Plan of Action at any time. If the Attorney 
General decides to use this authority, the Attorney General will notify 
the Chairperson as soon as possible, who will in turn notify 
Participants.

H. Expenses

    Participation in this Agreement does not confer funds to 
Participants, nor does it limit or prohibit any pre-existing source of 
funds. Unless otherwise specified, all expenses, administrative or 
otherwise, incurred by Participants associated with participation in 
this Agreement shall be borne exclusively by the Participants.

I. Record Keeping

    The Chairperson shall have primary responsibility for maintaining 
records in accordance with 44 CFR part 332, and shall be the official 
custodian of records related to carrying out this Agreement. Each 
Participant shall maintain for 5 years all minutes of meetings, 
transcripts, records, documents, and other data, including any 
communications with other Participants or with any other member of the 
Committee, including drafts, related to the carrying out of this 
Agreement or any Plan of Action or incorporating data or information 
received in the course of carrying out this Agreement or any Plan of 
Action. Each Participant agrees to produce to the Administrator, the 
Attorney General, and the Chairman of the FTC upon request any item 
that this section requires the Participant to maintain. Any record 
maintained in accordance with 44 CFR part 332 shall be available for 
public inspection and copying, unless exempted on the grounds specified 
in 5 U.S.C. 552(b)(1), (3) or (4) or identified as privileged and 
confidential information in accordance with DPA section 705(d), and 44 
CFR 332.5.

IV. Antitrust Defense

    Under the provisions of DPA subsection 708(j), each Participant in 
this Agreement shall have available as a defense to any civil or 
criminal action brought for violation of the antitrust laws (or any 
similar law of any State) with respect to any action to develop or 
carry out this Agreement or a Plan of Action, that such action was 
taken by the Participant in the course of developing or carrying out 
this Agreement or a Plan of Action, that the Participant complied with 
the provisions of DPA section 708 and the rules promulgated thereunder, 
and that the Participant acted in accordance with the terms of this 
Agreement and any relevant Plan of Action. Except in the case of 
actions taken to develop this Agreement or a Plan of Action, this 
defense shall be available only to the extent the Participant asserting 
the defense demonstrates that the action was specified in, or was 
within the scope of, this Agreement or a Plan of Action.
    This defense shall not apply to any action occurring after the 
termination of this Agreement or a Plan of Action. Immediately upon 
modification of this Agreement or a Plan of Action, no antitrust 
immunity shall apply to any subsequent action that is beyond the scope 
of the modified Agreement or Plan of Action. The Participant asserting 
the defense bears the burden of proof to establish the elements of the 
defense. The defense shall not be available if the person against whom 
the defense is asserted shows that the action was taken for the purpose 
of violating the antitrust laws.

V. Terms and Conditions

    Each Participant agrees to voluntarily collaborate with all 
Committee Members to recommend Plans of Action and Sub-Committees that 
will, at the direction of and under the supervision of FEMA, maximize 
the effectiveness of the manufacture and distribution of Critical 
Healthcare Resources nationwide to respond to a pandemic by 
establishing unity of effort between the Participants and the Federal 
Government for integrated coordination, planning, information sharing 
with FEMA, and allocation and distribution of Critical Healthcare 
Resources. These efforts aim to promote efficiency and timeliness to 
mitigate shortages of Critical Healthcare Resources to respond to a 
Pandemic and to meet the overall demands of the healthcare and other 
selected critical infrastructure sectors, along with those demands 
necessary to continue all-level-of-government mission-essential 
functions.
    As the sponsoring agency, FEMA will maintain oversight over 
Committee and Sub-Committee activities and direct and supervise actions 
taken to carry out this Agreement and subsequent Plans of Action, 
including by retaining decision-making authority over actions taken 
pursuant to this Agreement and subsequent Plans of Action to ensure 
such actions are necessary to address a direct threat to the national 
defense. The Department of Justice (DOJ) and the Chairman of the FTC 
will monitor activities of the Committee and Sub-Committees to ensure 
they execute their responsibilities in a manner consistent with this 
Agreement having the least anticompetitive effects possible.

A. Plan of Action Execution

    Specific Member obligations and actions to be undertaken will only 
be provided for in individual Plans of Action, not in the Agreement. 
Activities taken to develop a Plan of Action or to implement a Plan of 
Action that has been activated pursuant to section III.E. above will 
provide Participants the antitrust defense described in section

[[Page 50039]]

IV. Each Plan of Action will endeavor to clearly identify the conduct 
that Participants will undertake in carrying out the Plan of Action and 
that would be subject to the defense described in Section IV.
    Each Plan of Action will describe what information Members will 
share, as directed by FEMA and under FEMA's supervision. Information 
will be used to create a common operating picture in furtherance of the 
Plan of Action's purpose and/or to promote overall situational 
awareness of Critical Healthcare Resource manufacturing and 
distribution activities.
    Each Plan of Action, and information gathered pursuant to that 
plan, will be used to support one or more of the following objectives:
    (1) Facilitate maximum availability of Critical Healthcare 
Resources to end-users by deconflicting overlapping requirements for 
the collective Participant customer base;
    (2) Facilitate maximum availability of Critical Healthcare 
Resources to Members by deconflicting overlapping supply chain demands 
of Members;
    (3) Facilitate efficient distribution of Critical Healthcare 
Resources by deconflicting overlapping distribution chain activities of 
Members;
    (4) Inform where expansion of the manufacture of Critical 
Healthcare resources is necessary;
    (5) Identify and prioritize Critical Healthcare Resource 
requirements;
    (6) Validate Critical Healthcare Resource requirements;
    (7) Project future demand for Critical Healthcare Resource 
requirements.
    (8) Execute a collaborative manufacturing strategy to more 
efficiently make use of limited resources for key manufacturing lines 
of effort for Critical Healthcare Resources;
    (9) Collaborate in the voluntary Participant allocation of Critical 
Healthcare Resources nationwide;
    (10) Cooperate to the fullest extent possible to distribute 
Critical Healthcare Resources to locations most in need, as identified 
by FEMA;
    (11) Explore strategies for increased manufacturing of Critical 
Health Resources in or near the United States;
    (12) Carry out any other activities as determined and directed by 
FEMA necessary to address the Pandemic's direct threat to the national 
defense.

B. Information Management and Responsibilities

    FEMA will request only that data and information from Participants 
that is necessary to meet the objectives of a Plan of Action. Upon 
signing a Plan of Action Agreement, participants should endeavor to 
cooperate to the greatest extent possible to share data and information 
necessary to meet the objectives of the Plan of Action.
    The specific data requested, procedures for sharing that data, and 
data management and disposition will be tailored for each specific Plan 
of Action. Where feasible and to the greatest extent possible, FEMA 
will incorporate the following principles regarding data sharing into 
each Plan of Action:
     In general, Participants will not be asked to share 
competitively sensitive information directly with other Participants. 
Direct sharing of information among Participants will be requested only 
when necessary and will be closely supervised by FEMA, including 
requiring appropriate safeguards regarding participant use and 
dissemination of other participants' data.
     If FEMA needs to share information with parties outside 
the Sub-Committee, FEMA will limit the amount and type of information 
shared to the greatest extent feasible and permitted by law, while 
still furthering the objectives of the Plan of Action.
     Prior to distribution within or outside the Sub-Committee, 
FEMA will aggregate and anonymize data in such a way that will maximize 
the effectiveness of the Plan of Action without compromising 
competitively sensitive information.
     Pursuant to 5 U.S.C. 552(b)(4) and 44 CFR 332.5, FEMA will 
withhold from disclosure under the Freedom of Information Act 
Participant trade secrets and commercial or financial information and 
will restrict Sub-Committee meeting attendance where necessary to 
protect trade secrets and commercial or financial information.
     Any party receiving competitively sensitive information 
through a Plan of Action shall use such information solely for the 
purposes outlined in the Plan of Action and take steps, such as 
imposing firewalls or tracking usage, to ensure such information is not 
used for any other purpose. Disclosure and use of competitively 
sensitive information will be limited to the greatest extent possible.
     At the conclusion of a Participant's involvement in a Plan 
of Action--due to the deactivation of the Plan of Action or due to the 
Participant's withdrawal or removal--each Participant will be requested 
to sequester any and all competitively sensitive information received 
through participation in the Plan of Action. This sequestration will 
include the deletion of all competitively sensitive information unless 
required to be kept pursuant to the Record Keeping requirements as 
described supra, Section I, 44 CFR part 332, or any other provision of 
law.

C. Oversight

    The Chairperson is responsible for ensuring the Attorney General, 
or suitable delegate(s) from DOJ, and the FTC Chairman, or suitable 
delegate(s) from the FTC, have awareness of activities under this 
Agreement, including Plan of Action activation, deactivation, and 
scheduling of meetings. The Attorney General, the FTC Chairman, or 
their delegates may attend Committee and Sub-Committee meetings and 
request to be apprised of any activities taken in accordance with 
activities under this Agreement or a Plan of Action. DOJ or FTC 
Representatives may request and review any proposed action by the 
Committee, Sub-Committee or Participants undertaken pursuant to this 
Agreement or Plan of Action, including the provision of data. If any 
DOJ or FTC Representative believes any actions proposed or taken are 
not consistent with relevant antitrust protections provided by the DPA, 
he or she shall provide warning and guidance to the Committee as soon 
as the potential issue is identified. If questions arise about the 
antitrust protections applicable to any particular action, FEMA may 
request DOJ, in consultation with the FTC, provide an opinion on the 
legality of the action under relevant DPA antitrust protections.

VI. Establishment of the Committee

    There is established a Committee for the Manufacture and 
Distribution of Healthcare Resources Necessary to Respond to a Pandemic 
(Committee) to provide the Federal Government and the Participants a 
forum to maximize the effectiveness of the manufacture and distribution 
of Critical Healthcare Resources nationwide to respond to a Pandemic 
through integrated coordination, planning, and information sharing with 
FEMA. A Chairperson designated by the FEMA Administrator will convene 
and preside over the Committee. The Committee will not be used for 
widespread or collective exchange of information among members. These 
activities, if required, shall be done within individual Sub-
Committees, and in accordance with an established Plan of Action. The 
Committee will not be used for contract negotiations or contract 
discussions between the Participants and the Federal Government; such 
negotiations or discussions will be in accordance with applicable 
Federal contracting

[[Page 50040]]

policies and procedures. However, this shall not limit any discussion 
within a Sub-Committee about the operational utilization of existing 
and potential contracts between the Participants and Representatives 
when seeking to align their use with overall manufacturing and 
distribution efforts consistent with this Agreement and a Plan of 
Action.
    The Committee will consist of designated Representatives from FEMA, 
HHS, other Federal agencies with equities in this Agreement, and each 
Participant. The Attorney General and Chairman of the FTC, or their 
delegates, may also join the Committee and attend meetings at their 
discretion. Attendees may also be invited at the discretion of the 
Chairperson as subject matter experts, to provide technical advice, or 
to represent other Government agencies, but will not be considered part 
of the Committee.
    To the extent necessary to respond to the Pandemic and at the 
explicit direction of the Chairperson, the Committee Members will 
provide technical advice to each other as needed, share information 
collectively, identify and validate places and resources of the 
greatest need, project future manufacturing and distribution demands, 
collectively identify and resolve the allocation of scarce resources 
amongst all necessary public and private sector domestic needs, and as 
necessary, share vendor, manufacturer and distribution information, and 
take any other necessary actions to maximize the timely manufacture and 
distribution of Critical Healthcare Resources as determined necessary 
by FEMA to respond to the Pandemic. The Chairperson or his or her 
designee, at the Chairperson's sole discretion, will make decisions on 
these issues in order to ensure the maximum coordination, efficiency, 
and effectiveness in the use of Member's resources and will create and 
execute Plans of Action as needed. All Participants will be invited to 
open Committee meetings. For selected Committee meetings, attendance 
may be limited to designated Participants to meet specific operational 
requirements.
    The Committee Chairperson shall notify the Attorney General, the 
Chairman of the FTC, Representatives, and Participants of the time, 
place, and nature of each meeting and of the proposed agenda of each 
meeting to be held to carry out this Agreement. Additionally, the 
Chairperson shall provide for publication in the Federal Register of a 
notice of the time, place, and nature of each meeting. If a meeting is 
open, a Federal Register notice will be published reasonably in advance 
of the meeting. The Chairman may restrict attendance at meetings only 
on the grounds outlined by 44 CFR 332.5(c)(1)-(3). If a meeting is 
closed, a Federal Register notice will be published within 10 days of 
the meeting and will include the reasons why the meeting is closed 
pursuant to 44 CFR 332.3(c)(2).
    The Chairperson shall establish the agenda for each meeting, be 
responsible for adherence to the agenda, and provide for a written 
summary or other record of each meeting and provide copies of 
transcripts or other records to FEMA, the Attorney General, the 
Chairman of the FTC, and all Participants. The Chair shall take 
necessary actions to protect from public disclosure any data discussed 
with or obtained from Participants which a Participant has identified 
as a trade secret or as privileged and confidential in accordance with 
DPA sections 708(h)(3) and 705(d), or which qualifies for withholding 
under 44 CFR 332.5.
    The Administrator, in his or her sole discretion and after 
consultation with the Committee Members, will create Plans of Action 
and Sub-Committees for specific workstreams or functional areas 
requiring collective coordination, planning, and collaboration. These 
Sub-Committees shall be subject to the same rules, regulations and 
requirements of the Committee and any other rules or requirements 
deemed necessary by the Chairperson, the Administrator, or the Attorney 
General, after consultation with the Chairman of the FTC.

VII. Application and Agreement

    The Participant identified below hereby agrees to join in the 
Federal Emergency Management Agency sponsored Voluntary Agreement 
entitled Committee for the Manufacture and Distribution of Healthcare 
Resources Necessary to Respond to a Pandemic (Agreement) and to become 
a Participant in this Committee. This Agreement will be published in 
the Federal Register. This Agreement is authorized under section 708 of 
the Defense Production Act of 1950, as amended. Regulations governing 
this Agreement appear at 44 CFR part 332. The applicant, as 
Participant, agrees to comply with the provisions of section 708 of the 
Defense Production Act of 1950, as amended, the regulations at 44 CFR 
part 332, and the terms of this Agreement.

VIII. Assignment

    No Participant may assign or transfer this Agreement, in whole or 
in part, or any protections, rights or obligations hereunder without 
the prior written consent of the Chairperson. When requested, the 
Chairperson will respond to written requests for consent within 10 
business days of receipt.

-----------------------------------------------------------------------
(Company name)

-----------------------------------------------------------------------
(Name of authorized representative)

-----------------------------------------------------------------------
(Signature of authorized representative)

-----------------------------------------------------------------------
(Date)

-----------------------------------------------------------------------
Administrator (Sponsor)

-----------------------------------------------------------------------
(Date)

Pete Gaynor,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2020-18005 Filed 8-14-20; 8:45 am]
BILLING CODE 9111-19-P